Form 4 Tracker
Eton Pharmaceuticals, Inc.
ETON

24 insider filings · Latest: Oct 6, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 17, 2026Jun 17 3:43 PMAdams Jennifer McKie
Proposed Sale
50,000$32.37$1.6M—

View →

Jun 2, 2026Jun 2 8:48 PMGruber James R.
Proposed Sale
3,117$27.00$84.2K—

View →

May 28, 2026May 29 8:16 PMBRYNJELSEN SEANDirector, President & CEO
Sale
120,000$31.88$3.8M833,694(D)

View →

May 28, 2026May 28 7:12 PMBRYNJELSEN SEAN
Proposed Sale
120,000$32.40$3.9M—

View →

May 27, 2026May 27 10:28 PMDavid KrempaChief Business Officer
Sale
19,679$31.47$619.4K25,249(D)

View →

May 26, 2026May 27 10:28 PMDavid KrempaChief Business Officer
Sale
37,524$31.49$1.2M25,249(D)

View →

May 22, 2026May 27 10:28 PMDavid KrempaChief Business Officer
Sale
42,797$33.39$1.4M25,249(D)

View →

May 22, 2026May 22 8:24 PMKrempa David
Proposed Sale
100,000$35.00$3.5M—

View →

Jan 14, 2026Jan 14 10:17 PMKrempa David
Proposed Sale
1,942$15.62$30.3K—

View →

Jan 14, 2026Jan 14 10:09 PMGruber James R.
Proposed Sale
2,293$15.47$35.5K—

View →

Jan 14, 2026Jan 14 4:28 PMBRYNJELSEN SEAN
Proposed Sale
5,015$15.39$77.2K—

View →

Dec 12, 2025Dec 12 10:11 PMGruber James R.
Proposed Sale
5,450$16.88$92.0K—

View →

Dec 12, 2025Dec 12 10:05 PMBRYNJELSEN SEAN
Proposed Sale
8,035$16.88$135.6K—

View →

Dec 12, 2025Dec 12 9:50 PMErdogan-Trinkaus Ipek
Proposed Sale
99$16.91$1.7K—

View →

Dec 12, 2025Dec 12 9:46 PMKrempa David
Proposed Sale
7,545$16.88$127.4K—

View →

Aug 18, 2025Aug 19 9:15 PMGruber James R.
Proposed Sale
41,713$16.61$692.6K—

View →

Jun 12, 2025Jun 12 8:21 PMKrempa David
Proposed Sale
40,000$15.00$600.0K—

View →

Jun 3, 2025Jun 3 8:00 PMBRYNJELSEN SEAN
Proposed Sale
210,000$18.00$3.8M—

View →

← Previous

Page 2 of 2

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Oct 2, 2026Oct 6 8:49 PMDavid KrempaChief Business Officer
Option Exercise
10,522$0.0021,044(D)

View →

Aug 28, 2026Aug 31 8:06 PMPaul V MaierDirector
Option Exercise
50,000$3.780(D)

View →

Aug 28, 2026Aug 31 8:06 PMPaul V MaierDirector
Option Exercise
12,500$7.310(D)

View →

Aug 28, 2026Aug 28 8:51 PMPaul V MaierDirector
Option Exercise
50,000$3.780(D)

View →

Aug 24, 2026Aug 24 9:19 PMDavid KrempaChief Business Officer
Option Exercise
25,000$7.3170,000(D)

View →

Jul 31, 2026Aug 4 9:10 PMCharles J CasamentoDirector
Grant/Award
10,000—10,000(D)

View →

Jul 31, 2026Aug 4 9:04 PMJudith M. MatthewsChief Financial Officer
Grant/Award
32,246—32,246(D)

View →

Jul 31, 2026Aug 4 9:03 PMIpek Erdogan-TrinkausChief Commercial Officer
Grant/Award
80,000—80,000(D)

View →

Jul 31, 2026Aug 4 9:01 PMBRYNJELSEN SEANDirector, President & CEO
Grant/Award
128,985—128,985(D)

View →

Jul 31, 2026Aug 4 9:01 PMDavid KrempaChief Business Officer
Grant/Award
128,985—128,985(D)

View →

Jul 31, 2026Aug 4 8:57 PMPaul V MaierDirector
Grant/Award
10,000—10,000(D)

View →

Jul 31, 2026Aug 4 8:56 PMNorbert G RiedelDirector
Grant/Award
10,000—10,000(D)

View →

Jul 31, 2026Aug 4 8:55 PMJennifer Mckie AdamsDirector
Grant/Award
10,000—10,000(D)

View →

Jul 14, 2026Jul 14 9:28 PMBRYNJELSEN SEANDirector, President & CEO
Option Exercise
200,000$1.370(D)

View →

Jul 12, 2026Jul 14 9:28 PMBRYNJELSEN SEANDirector, President & CEO
Option Exercise
27,500$0.000(D)

View →

Jul 12, 2026Jul 13 8:36 PMDavid KrempaChief Business Officer
Option Exercise
10,000$0.000(D)

View →

Jun 26, 2026Jun 30 8:27 PMDavid KrempaChief Business Officer
Grant/Award
10,000—96,829(D)

View →

Jun 17, 2026Jun 17 9:08 PMJennifer Mckie AdamsDirector
Option Exercise
50,000$3.780(D)

View →

May 27, 2026May 27 10:28 PMDavid KrempaChief Business Officer
Option Exercise
19,679$3.58118,406(D)

View →

May 26, 2026May 27 10:28 PMDavid KrempaChief Business Officer
Option Exercise
37,524$1.3812,476(D)

View →

Page 1 of 2

Next →